{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:57:48Z","timestamp":1770519468782,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10549-019-05448-w","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T10:14:55Z","timestamp":1568974495000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies"],"prefix":"10.1007","volume":"179","author":[{"given":"Jungeun","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-0522","authenticated-orcid":false,"given":"Dong-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DooSeok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"issue":"26","key":"5448_CR1","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","volume":"319","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1988","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1988) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. an overview of 61 randomized trials among 28,896 women. N Engl J Med 319(26):1681\u20131692","journal-title":"N Engl J Med"},{"issue":"9472","key":"5448_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717","journal-title":"Lancet"},{"issue":"9869","key":"5448_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10\u00a0years versus stopping at 5\u00a0years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805\u2013816","journal-title":"Lancet"},{"issue":"2","key":"5448_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","volume":"94","author":"I Cohen","year":"2004","unstructured":"Cohen I (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94(2):256\u2013266","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5448_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0378-5122(96)01043-2","volume":"25","author":"FP Dijkhuizen","year":"1996","unstructured":"Dijkhuizen FP et al (1996) Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Maturitas 25(1):45\u201350","journal-title":"Maturitas"},{"issue":"5 (Pt 1)","key":"5448_CR6","first-page":"660","volume":"81","author":"E Lahti","year":"1993","unstructured":"Lahti E et al (1993) Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81(5 (Pt 1)):660\u2013664","journal-title":"Obstet Gynecol"},{"issue":"2","key":"5448_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/gyno.1994.1029","volume":"52","author":"I Cohen","year":"1994","unstructured":"Cohen I et al (1994) Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52(2):185\u2013190","journal-title":"Gynecol Oncol"},{"issue":"8634","key":"5448_CR8","first-page":"375","volume":"1","author":"HJ Stewart","year":"1989","unstructured":"Stewart HJ, Knight GM (1989) Tamoxifen and the uterus and endometrium. Lancet 1(8634):375\u2013376","journal-title":"Lancet"},{"issue":"2","key":"5448_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/gyno.2000.5859","volume":"78","author":"L Deligdisch","year":"2000","unstructured":"Deligdisch L et al (2000) Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 78(2):181\u2013186","journal-title":"Gynecol Oncol"},{"key":"5448_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1749-6632.1994.tb21761.x","volume":"734","author":"P Sismondi","year":"1994","unstructured":"Sismondi P et al (1994) Tamoxifen and endometrial cancer. Ann N Y Acad Sci 734:310\u2013321","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"5448_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"B Fisher","year":"1994","unstructured":"Fisher B et al (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86(7):527\u2013537","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"5448_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1046\/j.1525-1497.2003.20724.x","volume":"18","author":"RS Braithwaite","year":"2003","unstructured":"Braithwaite RS et al (2003) Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med 18(11):937\u2013947","journal-title":"J Gen Intern Med"},{"issue":"9484","key":"5448_CR13","first-page":"491","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F et al (2005) Endometrial cancer 366(9484):491\u2013505","journal-title":"Endometrial cancer"},{"issue":"1","key":"5448_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1005820115535","volume":"47","author":"G Bertelli","year":"1998","unstructured":"Bertelli G et al (1998) Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients. Breast Cancer Res Treat 47(1):41\u201346","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5448_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ygyno.2004.06.033","volume":"94","author":"O Markovitch","year":"2004","unstructured":"Markovitch O et al (2004) The value of sonohysterography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol 94(3):754\u2013759","journal-title":"Gynecol Oncol"},{"issue":"5","key":"5448_CR16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/1097-0142(20010901)92:5<1151::AID-CNCR1433>3.0.CO;2-Y","volume":"92","author":"I Cohen","year":"2001","unstructured":"Cohen I et al (2001) Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen. Cancer 92(5):1151\u20131155","journal-title":"Cancer"},{"issue":"9233","key":"5448_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","volume":"356","author":"L Bergman","year":"2000","unstructured":"Bergman L et al (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 356(9233):881\u2013887","journal-title":"Lancet"},{"issue":"4","key":"5448_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/00004347-199910000-00003","volume":"18","author":"I Cohen","year":"1999","unstructured":"Cohen I (1999) Endometrial cancers in postmenopausal breast cancer patients with tamoxifen treatment. Int J Gynecol Pathol 18(4):304\u2013309","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"5448_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ctrv.2011.06.009","volume":"38","author":"J Iqbal","year":"2012","unstructured":"Iqbal J et al (2012) Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev 38(4):318\u2013328","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5448_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ygyno.2005.03.036","volume":"98","author":"G Garuti","year":"2005","unstructured":"Garuti G et al (2005) Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women. Gynecol Oncol 98(1):63\u201367","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5448_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1471-0528.14385","volume":"124","author":"M Pennant","year":"2017","unstructured":"Pennant M et al (2017) Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG 124(3):404\u2013411","journal-title":"BJOG"},{"issue":"19","key":"5448_CR22","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","volume":"91","author":"L Bernstein","year":"1999","unstructured":"Bernstein L et al (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91(19):1654\u20131662","journal-title":"J Natl Cancer Inst"},{"issue":"8895","key":"5448_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","volume":"343","author":"FE van Leeuwen","year":"1994","unstructured":"van Leeuwen FE et al (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343(8895):448\u2013452","journal-title":"Lancet"},{"issue":"8630","key":"5448_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"333","author":"T Fornander","year":"1989","unstructured":"Fornander T et al (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 333(8630):117\u2013120","journal-title":"Lancet"},{"issue":"12","key":"5448_CR25","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/cncr.10587","volume":"94","author":"I Cohen","year":"2002","unstructured":"Cohen I et al (2002) Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women. Cancer 94(12):3101\u20133106","journal-title":"Cancer"},{"issue":"2","key":"5448_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0301-2115(96)02456-6","volume":"67","author":"T Be\u015fe","year":"1996","unstructured":"Be\u015fe T et al (1996) Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen. Eur J Obstet Gynecol Reprod Biol 67(2):157\u2013162","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"5448_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0002-9378(98)70294-7","volume":"179","author":"D Timmerman","year":"1998","unstructured":"Timmerman D et al (1998) A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 179(1):62\u201370","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"5448_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3892\/ol.2013.1156","volume":"5","author":"M Le Donne","year":"2013","unstructured":"Le Donne M et al (2013) Endometrial pathology in breast cancer patients: effect of different treatments on ultrasonographic, hysteroscopic and histological findings. Oncol Lett 5(4):1305\u20131310","journal-title":"Oncol Lett"},{"issue":"20","key":"5448_CR29","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","volume":"18","author":"B Gerber","year":"2000","unstructured":"Gerber B et al (2000) Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol 18(20):3464\u20133470","journal-title":"J Clin Oncol"},{"issue":"1","key":"5448_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0090-8258(03)00441-4","volume":"91","author":"MF Fung","year":"2003","unstructured":"Fung MF et al (2003) Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen. Gynecol Oncol 91(1):154\u2013159","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5448_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/gyno.1998.5316","volume":"73","author":"MJ Mourits","year":"1999","unstructured":"Mourits MJ et al (1999) Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Gynecol Oncol 73(1):21\u201326","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5448_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/00004347-199604000-00010","volume":"15","author":"I Cohen","year":"1996","unstructured":"Cohen I et al (1996) Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients. Int J Gynecol Pathol 15(2):152\u2013157","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"5448_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jcp.52.4.278","volume":"52","author":"I Cohen","year":"1999","unstructured":"Cohen I et al (1999) Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients. J Clin Pathol 52(4):278\u2013282","journal-title":"J Clin Pathol"},{"issue":"2","key":"5448_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/gyno.1997.4739","volume":"66","author":"WF Cheng","year":"1997","unstructured":"Cheng WF et al (1997) Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 66(2):233\u2013237","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5448_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1074-3804(05)80224-5","volume":"4","author":"D Marconi","year":"1997","unstructured":"Marconi D et al (1997) Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen. J Am Assoc Gynecol Laparosc 4(3):331\u2013339","journal-title":"J Am Assoc Gynecol Laparosc"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05448-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T23:11:47Z","timestamp":1600470707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05448-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5448"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05448-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent is not needed for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}